Key result
NSTEMI patients have ~91% higher non-culprit Gensini and SYNTAX scores than STEMI patients.
Why the study?
Patients with NSTEMI have worse long-term prognoses than those with STEMI, which may be attributable to more extended coronary atherosclerotic disease burden.
Do patients with NSTEMI have a higher non-culprit coronary atherosclerotic disease burden compared to patients with STEMI?
Observational (n=231)
No
Do patients with NSTEMI have a higher non-culprit coronary atherosclerotic disease burden compared to patients with STEMI?
Patients with NSTEMI have a significantly higher burden of non-culprit coronary atherosclerotic disease compared to those with STEMI, which may partly explain their worse long-term prognosis.
Answers are grounded in this paper and cite their sources.
Supports broader non-culprit assessment in NSTEMI; hypothesis-generating for differential secondary prevention pending prospective validation.
BACKGROUND: Patients with non-ST-elevation myocardial infarction (NSTEMI) have worse long-term prognoses than those with ST-elevation myocardial infarction (STEMI). HYPOTHESIS: It may be attributable to more extended coronary atherosclerotic disease burden in patients with NSTEMI. METHODS: This study consisted of consecutive 231 patients who underwent coronary intervention for myocardial infarction (MI). To assess the extent and severity of atherosclerotic disease burden of non-culprit coronary arteries, two scoring systems (Gensini score and synergy between percutaneous coronary intervention with Taxus and cardiac surgery [SYNTAX] score) were modified by subtracting the score of the culprit lesion: the non-culprit Gensini score and the non-culprit SYNTAX score. RESULTS: Patients with NSTEMI had more multi-vessel disease, initial thrombolysis in myocardial infarction (TIMI) flow grade 2/3, and final TIMI flow grade 3 than those with STEMI. As compared to STEMI, patients with NSTEMI had significantly higher non-culprit Gensini score (16.3 ± 19.8 vs. 31.2 ± 25.4, p < 0.001) and non-culprit SYNTAX score (5.8 ± 7.0 vs. 11.1 ± 9.7, p < 0.001). CONCLUSIONS: Patients with NSTEMI had more advanced coronary atherosclerotic disease burden including non-obstruction lesions, which may at least in part explain higher incidence of cardiovascular events in these patients.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2020) conducted an observational in Myocardial infarction (n=231). NSTEMI vs. STEMI was evaluated on Non-culprit Gensini score (p=<0.001). Patients with NSTEMI had higher non-culprit Gensini scores and non-culprit SYNTAX scores compared to patients with STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: